Today's Pre-Open Movers

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) 43% HIGHER; announced today that the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), and Biomedical Advanced Research and Development Authority (BARDA) has awarded the Company a 5-year contract, with an option to extend to 10-years, to support the development of Parateks NUZYRA® (omadacycline) for the treatment of pulmonary anthrax, FDA post-marketing requirements (PMR) associated with the initial NUZYRA approval, and the option to procure up to 10,000 treatment courses of NUZYRA for the Strategic National Stockpile (SNS) for use against potential biothreats.

Rite Aid (NYSE: RAD) 30% HIGHER; reported Q3 EPS of $0.54, $0.45 better than the analyst estimate of $0.09. Revenue for the quarter came in at $5.46 billion versus the consensus estimate of $5.42 billion. Rite Aid sees FY2020 revenue of $21.5-21.9 billion, versus the consensus of $21.64 billion.

Minerva Neurosciences, Inc. (NASDAQ: NERV) 20.8% LOWER; Neither dose of MIN-117 tested in this trial showed a statistically significant separation from placebo on the reduction in the symptoms of MDD over the 6-week treatment period as measured by the change in the MADRS. In addition, neither dose showed a statistically significant separation from placebo on the key secondary endpoint, reduction of symptoms of anxiety as measured by Hamilton Anxiety Rating Scale (HAM-A) over the 6-week treatment period. Patients treated with the 2.5 mg dose experienced an improvement of 1.6 points compared to placebo at Week 2 (p 0.029). No other statistically significant separation from placebo on HAM-A was observed.

Apogee Enterprises (NASDAQ: APOG) 17.9% LOWER; reported Q3 EPS of $0.57, $0.19 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $338 million versus the consensus estimate of $360.47 million. Apogee Enterprises sees FY2020 EPS of $2.15-$2.20, versus the consensus of $3.04.

Ampio Pharmaceuticals (NYSE: AMPE) 15.3% HIGHER; Roth Capital initiates coverage on with a Buy rating and a price target of $4.00.

Xperi Corporation (Nasdaq: XPER) 10.3% LOWER; Xperi and TiVo Corporation (Nasdaq: TIVO) today announced they entered into a definitive agreement to combine in an all-stock transaction, representing approximately $3 billion of combined enterprise value. The transaction creates a leading consumer and entertainment technology business and one of the industrys largest intellectual property (IP) licensing platforms with a diverse portfolio of entertainment and semiconductor intellectual property.

Herman Miller (NASDAQ: MLHR) 9.4% LOWER; reported Q2 EPS of $0.88, $0.01 better than the analyst estimate of $0.87. Revenue for the quarter came in at $674.2 million versus the consensus estimate of $697.1 million. Herman Miller sees Q3 2020 EPS of $0.68-$0.72, versus the consensus of $0.75. Herman Miller sees Q3 2020 revenue of $672-692 million, versus the consensus of $674.7 million. Axsome Therapeutics, Inc. (NASDAQ: AXSM) 6% HIGHER; intends to offer and sell shares of its common stock, subject to market and other conditions, in an underwritten public offering.

ConAgra Brands (NYSE: CAG) 8% HIGHER; reported Q2 EPS of $0.63, $0.06 better than the analyst estimate of $0.57. Revenue for the quarter came in at $2.82 billion versus the consensus estimate of $2.8 billion. ConAgra Brands sees FY2020 EPS of $2.07-$2.17, versus the consensus of $2.09.

TiVo Corporation (Nasdaq: TIVO) 7.9% HIGHER; Xperi Corporation (Nasdaq: XPER) and TiVo Corporation (Nasdaq: TIVO) today announced they entered into a definitive agreement to combine in an all-stock transaction, representing approximately $3 billion of combined enterprise value. The transaction creates a leading consumer and entertainment technology business and one of the industrys largest intellectual property (IP) licensing platforms with a diverse portfolio of entertainment and semiconductor intellectual property.

Rubicon Project (NYSE: RUBI) 6.6% HIGHER; and Telaria (NYSE: TLRA), the complete software platform that optimizes yield for leading video publishers, announced today that they have entered into a definitive agreement to combine in a stock-for-stock merger. The transaction, which has been unanimously approved by the Boards of Directors of both companies, will create the worlds largest independent sell-side advertising platform, poised to capture growth in CTV.

Green Dot Corporation (NYSE: GDOT) 6.6% LOWER; announced the retirement of Green Dot CEO and Founder, Steve Streit. Mr. Streit will also retire from Green Dots Holding Company Board and as Chairman of the Green Dot Bank board. Mr. Streits retirement initiates an orderly management succession and transition process under which Mr. Streit will transition to the role of Chief Innovation Officer as an independent advisor while Green Dot Board Chairman, William I. Jacobs, will serve as interim Chief Executive Officer and J. Christopher Brewster, Chair of the Audit Committee, will serve as interim president. As part of this process, Green Dot CFO, Mark Shifke, will retire concurrent to Mr. Streit and Jess Unruh, Operational Chief Financial Officer and Chief Accounting Officer, will serve as interim Chief Financial Officer. All transitions will become effective on December 31, 2019.

Karuna Therapeutics Inc. (NASDAQ: KRTX) 5.5% HIGHER; Stifel initiates coverage on with a Buy rating and a price target of $126.00.

Exicure, Inc. (NASDAQ: XCUR) 5.4% LOWER; announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Exicure intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of its common stock offered in the public offering. All of the shares are being offered by Exicure. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

New Age Beverages (NASDAQ: NBEV) 4.8% HIGHER; Director Timothy Haas bought 100,000 shares on 12/16 at $1.92.

ABM Industries (NYSE: ABM) 4.3% LOWER; reported Q4 EPS of $0.66, $0.04 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.65 billion versus the consensus estimate of $1.67 billion. ABM Industries sees FY2020 EPS of $1.90-$2.10, versus the consensus of $2.10.

Micron Technology (NASDAQ: MU) 4.2% HIGHER; reported Q1 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.01 billion. Micron Technology sees Q2 2020 EPS of $0.35 at mid-point, versus the consensus of $0.41. Micron Technology sees Q2 2020 revenue of $4.5-4.8 billion, versus the consensus of $4.78 billion.

Inovio Pharmaceuticals (NASDAQ: INO) 3.8% HIGHER; Roth Capital initiates coverage on Iwith a Buy rating and a price target of $13.00.

REV Group, Inc. (NYSE: REVG) 3.6% HIGHER; reported Q4 EPS of $0.05, $0.08 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $652.9 million versus the consensus estimate of $631.22 million. REV Group, Inc. sees FY2020 revenue of $2.45-2.6 billion, versus the consensus of $2.41 billion.

Western Digital Corporation (NYSE: WDC) 2.9% HIGHER; up on MU results